ORKA · Oruka Therapeutics, Inc. · Executive Compensation
$80.15
-1.00 (-1.23%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$5.31B
Shares
66.21M
Volume · Oct 23
514.02K
Avg daily vol (3M)
876.46K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Lawrence Klein | Chief Executive Officer | $3,356,050 |
| Paul Quinlan | General Counsel | $2,338,593 |
| Joana Goncalves | Chief Medical Officer | $2,338,593 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | Former President and Chief Operating Officer | $853,520 |
| C. Jeffrey Dekker | Former Chief Financial Officer | $756,604 |
| Lawrence Klein | Chief Executive Officer | $520,911 |
| Michael Bristow | Former President and Chief Executive Officer | $510,416 |
| Joana Goncalves | Chief Medical Officer | $317,986 |
| Paul Quinlan | General Counsel | $310,445 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | Former President and Chief Operating Officer | $400,802 |
| Michael Bristow | Former President and Chief Executive Officer | $358,800 |
| C. Jeffrey Dekker | Former Chief Financial Officer | $323,072 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | Chief Operating Officer | $448,993 |
| Michael Bristow | President and Chief Executive Officer | $358,800 |
| Michael R. Bristow | President and Chief Executive Officer | $358,800 |
| Christopher D. Ozeroff | Former Secretary, Senior Vice President and General Counsel | $316,429 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michael Bristow | President and Chief Executive Officer | $526,513 |
| Michael R. Bristow | President and Chief Executive Officer | $526,513 |
| Thomas A. Keuer | Chief Operating Officer | $420,615 |
| Christopher D. Ozeroff | Former Secretary, Senior Vice President and General Counsel | $366,029 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Bristow | President and Chief Executive Officer | $1,061,587 |
| Michael R. Bristow | President and Chief Executive Officer | $1,061,587 |
| Thomas A. Keuer | Chief Operating Officer | $631,024 |
| Christopher D. Ozeroff | Secretary, Senior Vice President and General Counsel | $555,848 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | Chief Operating Officer | $304,022 |
| Michael R. Bristow | President and Chief Executive Officer | $296,151 |
| Michael Bristow | President and Chief Executive Officer | $296,151 |
| Christopher D. Ozeroff | Secretary, Senior Vice President and General Counsel | $290,157 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | Chief Operating Officer | $326,786 |
| Michael R. Bristow | President and Chief Executive Officer | $320,490 |
| Michael Bristow | President and Chief Executive Officer | $320,490 |
| Christopher D. Ozeroff | Secretary, Senior Vice President and General Counsel | $310,257 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Todd Edwards | Chief Commercial Officer | Appointed | 2026-08-24 |
| Christopher Martin | Class II director | Appointed | 2025-12-11 |
| Cameron Turtle | member of the Board of Directors | Resigned | 2025-12-11 |
| Laura Sandler | Chief Operating Officer | Appointed | 2025-07-01 |
| Samarth Kulkarni | Chairman of Oruka's Board of Directors | Appointed | 2024-09-05 |
| Samarth Kulkarni | Chairman of Oruka's Board of Directors | Appointed | 2024-09-05 |
| Samarth Kulkarni | director (Class III) | Appointed | 2024-09-05 |
| Cameron Turtle | director (Class II) | Appointed | 2024-09-05 |
| Samarth Kulkarni | Chair of the Board | Appointed | 2024-09-05 |
| Kristine Ball | director (Class III) | Appointed | 2024-09-05 |
| Carl Dambkowski | director (Class I) | Appointed | 2024-09-05 |
| Joana Goncalves | Chief Medical Officer | Appointed | 2024-09-05 |
| Lawrence Klein | director (Class II) | Appointed | 2024-09-05 |
| Paul Quinlan | General Counsel and Secretary | Appointed | 2024-09-05 |
| Arjun Agarwal | Senior Vice President, Finance and Treasurer | Appointed | 2024-09-05 |
| Lawrence Klein | President and Chief Executive Officer | Appointed | 2024-09-05 |
| Jacob Ma-Weaver | ARCA's board of directors | Resigned | 2024-09-05 |
| James Flynn | ARCA's board of directors | Resigned | 2024-09-05 |
| Anders Hove | ARCA's board of directors | Resigned | 2024-09-05 |
| Robert Conway | ARCA's board of directors | Resigned | 2024-09-05 |
| Linda Grais | ARCA's board of directors | Resigned | 2024-09-05 |
| Thomas A. Keuer | President and principal executive officer | Appointed | 2024-04-04 |
| Michael Bristow | Director | Resigned | 2024-04-04 |
| Michael Bristow | President, Chief Executive Officer and Director | Resigned | 2024-04-04 |
| Dan Mitchell | board of directors | Resigned | 2024-02-06 |
Leadership
- Lawrence Klein CEO, Board Member
- Thomas A. Keuer CEO
- Samarth Kulkarni Chairman, Board Member
- C. Jeff Dekker CFO
- C. Jeffrey Dekker CFO
- Laura Sandler COO
- Paul Quinlan General Counsel
- Anders Hove Board Member
- Cameron Turtle Board Member
- Carl Dambkowski Board Member
- Chris Martin Board Member
- Christopher Martin Board Member
- Dr. Michael R. Bristow Board Member
- James Flynn Board Member
- Kristine Ball Board Member
- Linda Grais Board Member
- Michael R. Bristow Board Member
- Peter Harwin Board Member
- Robert E. Conway Board Member
Key facts
CIK
907654
CUSIP
687604108
13F (30d)
22 filings
22 filers
Visit website
Investor relations